NCM · Biotechnology

SILO (SILO) Stock

$4.40 -1.57% NCM: SILO Healthcare

Valuation

MetricValue
Price$4.40
Market Cap$4.97M
P/E Ratio-0.74
P/B Ratio0.86
P/S Ratio41.78
EPS (TTM)$-0.50
52-Week High$15.15
52-Week Low$3.31
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-74.57%
ROA-35.63%
ROCE-57.14%
Gross Margin-3.29%
Operating Margin-66.31%
Net Margin-67.17%
Debt/Equity0.00
Current Ratio7.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-3.0M$-4.0M$-4.0M$-5.0M$-4.0M
Net Profit$4.0M$-4.0M$-4.0M$-4.0M$-4.0M
EPS$1.30$-1.71$-1.20$-1.19$-0.50
Op Margin-3850.9%-5031.3%-5347.4%-6526.4%-5936.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.0M$12.0M$8.0M$7.0M$8.0M
Total Liabilities$1.0M$1.0M$2.0M$2.0M$1.0M
Cash$10.0M$11.0M$4.0M$4.0M$5.0M
Borrowings$0$0$0$0$0

Latest News

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? Insider Monkey · Jul 15, 2026 Silo Pharma’s QwikAgents Joins AMD AI Developer Program to Advance AI Agent Platform InvestorsHub · Jul 14, 2026 Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform GlobeNewswire · Jul 14, 2026 Top Midday Decliners MT Newswires · Jul 10, 2026 Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO) InvestorsHub · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-3.0M$-3.0M$-4.0M$-5.0M
Investing Cash Flow$7.0M$0$-4.0M$1.0M$1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$9.0M$2.0M$-8.0M$0$1.0M
Free Cash Flow$-2.0M$-3.0M$-3.0M$-4.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-127.60%
Quick Ratio9.65
Interest Coverage—
Return 1Y-43.48%
Return 3Y-84.07%
Return 5Y-96.75%

Ownership

Insiders Held16.41%
Institutions Held11.13%
Institutions Float Held13.31%
Institutional HolderSharesReport Date
AdvisorShares Investments, LLC44,2652026-03-31
FNY Investment Advisers, LLC37,5072026-06-30
Geode Capital Management, LLC12,0022026-03-31
Susquehanna International Group, LLP4,1862026-03-31
Jane Street Group, LLC2,9842026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BDRXBiodexa Pharmaceuticals Plc $1.71 -3.39% 0.00 $1.28M 0.00%
CANFCan-Fite BioPharma Ltd. $3.30 -2.37% -0.74 $1.78M 0.00%
CMND $1.62 +0.52% -0.79 $2.41M 0.00%
CNSP $5.40 +0.75% -0.14 $3.10M 0.00%
GRI $1.46 -5.81% -0.33 $131155 0.00%

About SILO

SILO is led by CEO Eric Weisblum, employs 3 people, headquartered in US, publicly traded since 2021.

SILO stock trades at $4.40 with a market capitalization of $4.97M. The stock is valued at a price-to-earnings (P/E) ratio of -0.74, price-to-book of 0.86, price-to-sales of 41.78. Over the past 52 weeks the stock has ranged between $3.31 and $15.15, and currently trades 71.0% below its 52-week high.

On profitability, SILO generates a return on equity (ROE) of -74.57%, return on capital employed of -57.14%, an operating margin of -66.31%, a net profit margin of -67.17%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides